Consolidations Present Investment Entry Opportunity
LeMaitre Vascular's stock demonstrates promising prospects for investors seeking long-term gains, especially considering recent consolidations in the market that have created an appealing entry point.
Strong Q2 Performance and Anticipated Continued Value Generation
The company recently reported record-breaking...
Interesting accumulation area developing with rising RSI, suggesting upward pressure could build up.
Look for a breakout confirmed by weekly close and increase in volume.
Contextual immersion trading strategy idea.
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide.
The demand for shares of the company looks higher than the supply.
This and other conditions can cause a rise in the share price in the next days.
So I...
Sales grew 9% to $28.4 million. That was well ahead of the $25.9 million that analysts had projected.
Operating income surged 14% to $7.2 million.
Net income grew 41% to $6 million, or $0.30 per share. That figure blew past the $0.20 that Wall Street was expecting.
The board of directors approved a 21% increase to the quarterly dividend and gave the thumbs-up to...
Low liquidity necessisates a limit order. Will buy on a pullback to 9.35
This trade feels uncomfortable as I would have rather if it went down to the lower trendline, but uncumfortable seems to be working well these days, so be it.
